BIOQUAL, Inc.
BIOQ
$72.50
-$2.50-3.33%
| 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -9.33% | -6.10% | -5.27% | 0.81% | 13.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.33% | -6.10% | -5.27% | 0.81% | 13.52% |
| Cost of Revenue | 0.80% | 2.55% | 2.25% | 5.92% | 18.66% |
| Gross Profit | -38.40% | -30.81% | -26.69% | -13.07% | 0.95% |
| SG&A Expenses | 8.88% | 8.55% | 7.90% | 11.89% | 9.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.23% | 3.62% | 3.26% | 6.96% | 16.99% |
| Operating Income | -114.03% | -95.17% | -83.12% | -46.75% | -10.54% |
| Income Before Tax | -110.90% | -93.64% | -82.77% | -46.47% | -10.60% |
| Income Tax Expenses | -120.53% | -94.90% | -77.38% | -71.31% | -30.72% |
| Earnings from Continuing Operations | -108.44% | -93.33% | -84.12% | -37.68% | -3.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -108.44% | -93.33% | -84.12% | -37.68% | -3.45% |
| EBIT | -114.03% | -95.17% | -83.12% | -46.75% | -10.54% |
| EBITDA | -81.78% | -66.70% | -59.00% | -33.38% | -4.88% |
| EPS Basic | -108.44% | -93.32% | -84.12% | -37.68% | -3.45% |
| Normalized Basic EPS | -110.90% | -93.64% | -82.77% | -46.47% | -10.60% |
| EPS Diluted | -108.55% | -93.40% | -84.19% | -37.64% | -3.38% |
| Normalized Diluted EPS | -110.90% | -93.64% | -82.77% | -46.47% | -10.60% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -50.00% | -50.00% | -50.00% | -20.00% | -20.00% |
| Payout Ratio | -6.92% | 10.99% | 4.04% | 0.28% | -0.17% |
